"The
Report Global Wet Age Related Macular Degeneration (AMD) Market:
Industry Analysis & Outlook (2017-2021) provides information
on pricing, market analysis, shares, forecast, and company profiles
for key industry participants. - MarketResearchReports.biz"
MarketResearchReports.biz has
recently added the report titled, “Global
Wet Age Related Macular Degeneration (AMD) Market:
Industry Analysis & Outlook (2017-2021)” to its repository. It
evaluates the major catalysts, deterrents, trends, and opportunities
in the market, alongside market projections. An assessment of the
leading segments of the market, analysis of the value chain, and
description of the competitive landscape have been included in the
report.
Age-related macular degeneration
(AMD) is a common condition of the eye that affects vision in people
aged 50 and older. There are two basic categories of macular
degeneration, dry and wet macular degeneration. Nearly 10 to 15% of
the reported cases of macular degeneration are of the ‘wet’ type.
In ‘wet’ macular degeneration, growth of abnormal blood vessels,
also known as choroidal neovascularization or CNV, takes place under
the macula and retina. This causes the macula to lift up or bulge,
thus leading to distortion of central vision. Consequently, vision
loss can be rapid and severe.
Owing to the phenomenal growth of
the geriatric population worldwide, the global market for wet
age-related macular degeneration is likely to witness an upsurge over
the forthcoming period. In the U.S., one in every seven people is an
aged person. The geriatric population was estimated to be 14.5% of
the overall population, numbered at 46.2 million in 2014, according
to the findings of the Administration for Community Living under the
U.S. Department of Health and Human Services.
Get
Sample Copy Of This Report @
The growing prevalence of
lifestyle disorders such as obesity, depression, hypertension, and
cardiovascular disorders has been driving the market for wet age
related macular degeneration market. People in the Asian countries
such as India and China are witnessing a high prevalence of the
disease. Fortunately, several market players and researchers are
developing a number of treatment options. Although repeated
treatments are mandatory, doctors are attempting to space the
treatments further apart and yet maintain effectiveness. The
emergence of personalized medicine has also been aiding the growth of
the market.
View Press Release @
http://www.marketresearchreports.biz/pressrelease/4405
By geography, North America is
expected to hold the leading position in the global market for wet
age related macular degeneration. Growth in healthcare
infrastructure, high awareness about the disease among people and
healthcare providers, and presence of leading market players in the
region has been promoting the growth of the wet age related macular
degeneration in North America. Asia Pacific is expected to represent
a major share in the global market for wet age related macular
degeneration in the oncoming years, thanks to the increasing patient
pool and rising availability of treatments for wet age related
macular degeneration.
The market for wet age related
macular degeneration is consolidated in terms of competition. The
report profiles the leading market players such as Novartis
International AG, Regeneron Pharmaceuticals, Inc., Bayer Group, and
Roche Holding AG.
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment